ViroCyt Inc.

Industry

  • Biotechnology
    • Large Molecule
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
    • Vaccines
  • Research, Analytical Equipment & Supplies
See more in Biomedtracker

Latest on ViroCyt Inc.

In Vivo

Device/Diagnostics Quarterly Deal-Making Statistics, Q1 2017

 
• By Amanda Micklus and Maureen Riordan

Device Transactions Financing by device companies in the first quarter of 2017 totaled $2.3 billion, slightly lower than Q4 2016's $2.4 billion. Notably, early-stage venture capital fundraising made u

In Vivo

Deals In Depth: June/July 2016

 
• By Amanda Micklus

Open Media Strategic Transactions

In Vivo

Deals Shaping the Medical Industry, August 2016

 
• By Beth Allan, Deanna Kamienski, Amanda Micklus, Steven Muntner, and Maureen Riordan

IN VITRO DIAGNOSTICS Alliances Cleveland HeartLab LLC Global Discovery Biosciences Global Discovery Biosciences licensed Cleveland HeartLab Inc. exclusive rights to distribute its PULS ( Prote

Scrip

Venture Funding Deals, September 2015

 
• By Deanna Kamienski, Beth Allan, Amanda Micklus, Maureen Riordan, and Steven Muntner

IN VITRO DIAGNOSTICS 23andMe Inc. 23andMe completes $150mm Series E financing 23andMe Inc. , which sells DNA testing kits directly to consumers who contribute their data to large-scale genetic